CRVO CervoMed Inc
21,176
$23.92
$0.02
(0.08%)
| Watchers | 21,176 |
| 52-Wk Low | $4.14 |
| 52-Wk High | $26.38 |
| Market Cap | $201.31M |
| Volume | 6,516.00 |
| 52-Wk High | $26.38 |
| 52-Wk Low | $4.14 |
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register NowGlobe Newswire • about 1 month ago
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The...
Share to Feed
MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024...
CervoMed: H2 2024 Data For DLB Program A Major Inflection Point...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
- Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash...
Cervomed Inc. (CRVO) has disclosed a new risk, in the Economy & Political Environment category. Cervomed Inc. faces considerable business risk due...
Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital $50 million financing upfront with up to an additional $99.4 million tied...
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that...
This is a Bearish indicator signaling CRVO's price could decline from here. Traders may explore shorting the stock or put options...
This is a signal that CRVO's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...